Market Overview:
The global blood collection devices market covers medical tools used to collect, contain, transport, and prepare blood specimens for diagnostic and therapeutic procedures. The market includes blood collection tubes, needles and syringes, blood bags, blood collection systems and monitors, lancets, and other related devices.

Key Market Drivers & Trends:
Rising prevalence of chronic diseases, including cardiovascular conditions, diabetes, autoimmune disorders, and cancer, is increasing the volume of diagnostic blood testing. Growing preventive screening, expanding healthcare access, safety regulations, minimally invasive collection technologies, automation, and the adoption of smart blood collection solutions are influencing market development.

Market Segmentation:
The market is segmented by product type, end-user, application, and method. Product types include blood collection tubes, needles and syringes, blood bags, blood collection systems and monitors, lancets, and others. End-users include hospitals and ASCs, diagnostics and pathology laboratories, blood banks, and others, while applications comprise diagnostic and therapeutic applications. Methods include manual and automated blood collection.

Regional Insights:
North America represents the largest regional market for blood collection devices, while Asia-Pacific is identified as the fastest-growing market during the forecast period. The regional assessment covers North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Competitive Landscape / Key Players:
The global blood collection devices market includes established medical-device and healthcare companies competing across blood collection consumables, safety-engineered devices, blood bags, automated collection systems, and related technologies. Key companies profiled include Medline Industries, LP, Becton Dickinson, Cardinal Health, Inc., Abbott Laboratories, ICU Medical Inc., McKesson Corporation, Terumo Corporation, Nipro Corporation, Thermo Fisher Scientific Inc., QIAGEN N.V., Retractable Technologies Inc., Sarstedt AG & Co. KG, SB-Kawasumi Laboratories, Inc., Greiner Holding AG, Fresenius Kabi AG, Haemonetics Corporation, Sol-Millennium Medical Group, F.L. Medical S.r.l., Macopharma S.A., and Sekisui Medical Co., Ltd.

Recent Developments:
Recent developments in the market include advances in vacuum blood collection tubes, autonomous robotic blood collection systems, capillary blood collection solutions, and dried blood spot technologies. These developments reflect ongoing efforts to improve collection efficiency, minimize sample volumes, enhance workflow processes, and support decentralized and remote diagnostic applications.

Report Scope:
The report covers the historical period 2020-2024, with 2025 as the base year and 2026-2031 as the forecast period. The global blood collection devices market is valued at USD 8.73 billion in 2025 and is projected to reach USD 13.08 billion by 2031, representing a CAGR of 7.14% during 2026-2031.

Contact us:
Steven Thomas - Sales & Marketing Manager
E-mail: [email protected]
Asia-Pacific: +91 7878231309
Europe: +44 20 8089 0049
North America: +1 201 793 8545
https://www.bonafideresearch.com/